Barclays’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.22M | Sell |
79,159
-264,299
| -77% | -$16.8M | ﹤0.01% | 1793 |
|
|
2025
Q4 | $21.8M | Sell |
343,458
-54,617
| -14% | -$3.4M | 0.01% | 1211 |
|
|
2025
Q3 | $21.9M | Sell |
398,075
-94,739
| -19% | -$3.9M | 0.01% | 1190 |
|
|
2025
Q2 | $16.3M | Buy |
492,814
+183,322
| +59% | +$6.38M | 0.01% | 1251 |
|
|
2025
Q1 | $12.4M | Sell |
309,492
-78,641
| -20% | -$3.61M | 0.01% | 1272 |
|
|
2024
Q4 | $18.3M | Buy |
388,133
+11,137
| +3% | +$578K | 0.01% | 1180 |
|
|
2024
Q3 | $19.9M | Buy |
376,996
+94,618
| +34% | +$5.27M | 0.01% | 1066 |
|
|
2024
Q2 | $15.3M | Sell |
282,378
-479,869
| -63% | -$29M | 0.01% | 1029 |
|
|
2024
Q1 | $53.4M | Buy |
762,247
+297,524
| +64% | +$23M | 0.02% | 590 |
|
|
2023
Q4 | $38.8M | Sell |
464,723
-107,544
| -19% | -$3.89M | 0.02% | 781 |
|
|
2023
Q3 | $16.9M | Buy |
572,267
+426,921
| +294% | +$14.2M | 0.01% | 807 |
|
|
2023
Q2 | $4.74M | Sell |
145,346
-195,926
| -57% | -$7.25M | ﹤0.01% | 1376 |
|
|
2023
Q1 | $12M | Sell |
341,272
-55,915
| -14% | -$2.28M | 0.01% | 1082 |
|
|
2022
Q4 | $18.2M | Sell |
397,187
-4,066
| -1% | -$175K | 0.02% | 937 |
|
|
2022
Q3 | $19.4M | Buy |
401,253
+72,972
| +22% | +$3.51M | 0.02% | 613 |
|
|
2022
Q2 | $12.9M | Buy |
328,281
+247,104
| +304% | +$9.95M | 0.01% | 906 |
|
|
2022
Q1 | $2.99M | Sell |
81,177
-24,412
| -23% | -$867K | ﹤0.01% | 1560 |
|
|
2021
Q4 | $4.81M | Buy |
105,589
+22,295
| +27% | +$860K | ﹤0.01% | 1734 |
|
|
2021
Q3 | $2.98M | Buy |
83,294
+30,153
| +57% | +$888K | ﹤0.01% | 2031 |
|
|
2021
Q2 | $1.05M | Sell |
53,141
-82,746
| -61% | -$1.94M | ﹤0.01% | 2633 |
|
|
2021
Q1 | $3.16M | Sell |
135,887
-49,445
| -27% | -$1.06M | ﹤0.01% | 1905 |
|
|
2020
Q4 | $3.85M | Sell |
185,332
-9,463
| -5% | -$173K | ﹤0.01% | 1705 |
|
|
2020
Q3 | $4.22M | Buy |
194,795
+61,488
| +46% | +$1.44M | 0.01% | 1510 |
|
|
2020
Q2 | $3.14M | Buy |
133,307
+84,397
| +173% | +$1.58M | 0.01% | 1734 |
|
|
2020
Q1 | $577K | Sell |
48,910
-38,181
| -44% | -$487K | ﹤0.01% | 3474 |
|
|
2019
Q4 | $924K | Sell |
87,091
-24,651
| -22% | -$253K | ﹤0.01% | 3741 |
|
|
2019
Q3 | $1.27M | Buy |
111,742
+46,783
| +72% | +$587K | ﹤0.01% | 3421 |
|
|
2019
Q2 | $731K | Buy |
64,959
+31,128
| +92% | +$300K | ﹤0.01% | 3998 |
|
|
2019
Q1 | $274K | Buy |
33,831
+10,782
| +47% | +$79.3K | ﹤0.01% | 4588 |
|
|
2018
Q4 | $145K | Sell |
23,049
-32,952
| -59% | -$242K | ﹤0.01% | 4794 |
|
|
2018
Q3 | $552K | Buy |
56,001
+31,669
| +130% | +$254K | ﹤0.01% | 4187 |
|
|
2018
Q2 | $202K | Buy |
24,332
+721
| +3% | +$6K | ﹤0.01% | 4715 |
|
|
2018
Q1 | $171K | Buy |
23,611
+4,314
| +22% | +$37K | ﹤0.01% | 4964 |
|
|
2017
Q4 | $157K | Buy |
19,297
+3,794
| +24% | +$43.1K | ﹤0.01% | 4893 |
|
|
2017
Q3 | $225K | Sell |
15,503
-8,963
| -37% | -$122K | ﹤0.01% | 4324 |
|
|
2017
Q2 | $296K | Buy |
24,466
+17,064
| +231% | +$237K | ﹤0.01% | 4018 |
|
|
2017
Q1 | $95K | Sell |
7,402
-7,922
| -52% | -$92.6K | ﹤0.01% | 4916 |
|
|
2016
Q4 | $186K | Buy |
15,324
+4,944
| +48% | +$52.5K | ﹤0.01% | 4274 |
|
|
2016
Q3 | $96K | Buy |
10,380
+2,666
| +35% | +$27.8K | ﹤0.01% | 4535 |
|
|
2016
Q2 | $73K | Buy |
7,714
+76
| +1% | +$624 | ﹤0.01% | 4616 |
|
|
2016
Q1 | $53K | Buy |
7,638
+7,510
| +5,867% | +$54.9K | ﹤0.01% | 4722 |
|
|
2015
Q4 | $1K | Sell |
128
-54
| -30% | -$530 | ﹤0.01% | 5810 |
|
|
2015
Q3 | $1K | Sell |
182
-577
| -76% | -$3.94K | ﹤0.01% | 6520 |
|
|
2015
Q2 | $5K | Sell |
759
-3,596
| -83% | -$23.6K | ﹤0.01% | 6438 |
|
|
2015
Q1 | $27K | Sell |
4,355
-923
| -17% | -$6.89K | ﹤0.01% | 5670 |
|
|
2014
Q4 | $42K | Sell |
5,278
-29,642
| -85% | -$127K | ﹤0.01% | 5849 |
|
|
2014
Q3 | $104K | Buy |
34,920
+34,360
| +6,136% | +$144K | ﹤0.01% | 5286 |
|
|
2014
Q2 | $2K | Sell |
560
-88,003
| -99% | -$537K | ﹤0.01% | 7392 |
|
|
2014
Q1 | $797K | Buy |
88,563
+87,973
| +14,911% | +$796K | ﹤0.01% | 3487 |
|
|
2013
Q4 | $3K | Sell |
590
-281
| -32% | -$1.85K | ﹤0.01% | 7267 |
|
|
2013
Q3 | $6K | Buy |
+871
| New | +$9.34K | ﹤0.01% | 6928 |
|
Other funds holding CYTK
VPM
VCM
ACA
